Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Surprising Company Taking On America's Most Fatal Disease
Motley Fool
Friday, November 1, 2013 - 11:46am
tags:
Ranexa, Gilead Sciences, angina, cardiovascular disease
Profit Expected to Dip for Regeneron Pharmaceuticals
Forbes
Friday, November 1, 2013 - 11:44am
tags:
earnings, Regeneron
A Closer Look at Pfizer's Oncology Business
Motley Fool
Friday, November 1, 2013 - 10:33am
tags:
oncology, Pfizer
Pfizer: What Will Drive The Behemoth Forward?
Seeking Alpha
Friday, November 1, 2013 - 10:32am
tags:
Pfizer, Remoxy, Durect Corporation, Pain Therapeutics, Zogenix
ViroPharma Beats by a Penny
Yahoo/Zacks
Friday, November 1, 2013 - 10:15am
tags:
ViroPharma, earnings
With shares down almost 90 percent on drug side effect concerns, Ariad adopts 'poison pill'
Yahoo/AP
Friday, November 1, 2013 - 10:13am
tags:
poison pill, Ariad Pharmaceuticals, Iclusig
Federal government shutdown stalled 100 medical device submissions
Mass Device
Friday, November 1, 2013 - 9:53am
tags:
devices
Cheaper By The Dozen? J&J Is Sued Over 340B Drug Discounts
Pharmalot
Friday, November 1, 2013 - 9:51am
tags:
JNJ, 340B, drug discounts
Gentium: Posts Strong Q3 Beat And Remains Attractive
Seeking Alpha
Friday, November 1, 2013 - 9:40am
tags:
Gentium, earnings
Is A Storm Brewing At Teva?
Seeking Alpha
Friday, November 1, 2013 - 9:40am
tags:
Teva
Zalicus announces Z944 Phase 1b clinical study positive results
Yahoo/Fly on the Wall
Friday, November 1, 2013 - 9:25am
tags:
Zalicus, Z944
U.S. FDA outlines plan to combat drug shortages
Yahoo/Reuters
Friday, November 1, 2013 - 8:39am
tags:
FDA, drug shortages
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months
Motley Fool
Friday, November 1, 2013 - 8:38am
tags:
patents, Amgen, Neupogen, Merck KGaA, Rebif, Cymbalta, Eli Lilly
Analysis: For Merck, bringing cattle feed Zilmax back won't be easy
Yahoo/Reuters
Friday, November 1, 2013 - 8:34am
tags:
Merck, Zilmax, animal health
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Forbes
Friday, November 1, 2013 - 8:28am
tags:
Pfizer, PCSK9 inhibitors, RN-316, Sanofi, Regeneron, REGN727, AMG145, Amgen
2 Drug Promotions Going in Opposite Directions
Motley Fool
Friday, November 1, 2013 - 8:26am
tags:
Amarin, Vascepa, Arena Pharmaceuticals, Eisai
Judge Invalidates Patent for a Down Syndrome Test
NY Times, NY
Friday, November 1, 2013 - 8:23am
tags:
Downs Syndrome, patents, Sequenom
Clovis Oncology's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Seeking Alpha
Friday, November 1, 2013 - 8:22am
tags:
earnings, Clovis Oncology
Uh Oh Arena Pharma! Q3 Belviq Sales Just $4.8M
TheStreet.com
Friday, November 1, 2013 - 8:20am
tags:
Arena Pharmaceuticals, Belviq, Eisai, obesity
Novo Nordisk recruiting 400 U.S. sales reps as growth decelerates
Fierce Pharma
Thursday, October 31, 2013 - 11:36am
tags:
hirings, Novo Nordisk

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.